HRT · Local vaginal estrogen
For the symptoms that nobody talks about — and that don't go away on their own.
Vaginal dryness, painful sex, urinary urgency, recurrent UTIs — these aren't a separate condition. They're genitourinary syndrome of menopause, and they're the predictable result of estrogen falling away from the tissues that depend on it. Local vaginal estradiol — cream or insert — treats it directly, with very little hormone reaching the bloodstream. For many women, this is the most underrated, highest-impact piece of menopause care.
Why local matters
The vaginal and urinary tissues have a high density of estrogen receptors. After menopause, with systemic estradiol low, those tissues thin, lose elasticity, dry out, and become more susceptible to infection. Roughly half of post-menopausal women experience this — and unlike hot flashes, it doesn't get better on its own. It typically gets worse.
Local vaginal estradiol delivers a small amount of hormone directly to the tissue that needs it. Blood levels stay near the post-menopausal baseline; the local effect on tissue is meaningful. The safety profile is favorable enough that vaginal estradiol is sometimes appropriate even for women with histories that rule out systemic HRT — that's a clinician judgment, but the menopause societies have moved toward more permissive use here than they were a decade ago.
This is one of the highest-leverage interventions in menopause care, and one of the most under-prescribed. If the symptoms are showing up for you, raising it in your assessment is the right move — women routinely report that this single piece changes how their body feels in a way nothing else did.
How it's used
Side effects & safety
Most common: mild local irritation in the first week, occasional discharge, brief itching during the loading phase. These are typically transient.
Less common but worth flagging: spotting (especially during loading — usually settles, but report any persistent bleeding), recurrent yeast or bacterial infections (sometimes a sign of tissue still adjusting), allergic reaction to the vehicle.
Compared to systemic HRT: the safety profile of low-dose vaginal estradiol is meaningfully different. Systemic absorption is minimal, and current menopause society guidance is that vaginal estrogen is often appropriate even for women whose history rules out systemic HRT — though the decision is individual and your clinician makes it.
Not appropriate without clinician review if: you have a personal history of certain hormone-sensitive cancers, unexplained vaginal bleeding, or active genital infection. Your assessment surfaces these factors carefully.
Questions
The 3-minute symptoms assessment is free. Your clinician follows up within 24 hours with a personalized recommendation.
Take the menopause assessment